Ryback ME - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen.

Morse MA, Deng Y, Coleman D, Hull S, Kitrell-Fisher E, Nair S, Schlom J, Ryback ME, Lyerly HK. Morse MA, et al. Among authors: ryback me. Clin Cancer Res. 1999 Jun;5(6):1331-8. Clin Cancer Res. 1999. PMID: 10389916 Clinical Trial.

Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma.

Lau R, Wang F, Jeffery G, Marty V, Kuniyoshi J, Bade E, Ryback ME, Weber J. Lau R, et al. Among authors: ryback me. J Immunother. 2001 Jan-Feb;24(1):66-78. doi: 10.1097/00002371-200101000-00008. J Immunother. 2001. PMID: 11211150 Clinical Trial.

Phase II study of R115777, a farnesyl transferase inhibitor, in myelodysplastic syndrome.

Kurzrock R, Albitar M, Cortes JE, Estey EH, Faderl SH, Garcia-Manero G, Thomas DA, Giles FJ, Ryback ME, Thibault A, De Porre P, Kantarjian HM. Kurzrock R, et al. Among authors: ryback me. J Clin Oncol. 2004 Apr 1;22(7):1287-92. doi: 10.1200/JCO.2004.08.082. J Clin Oncol. 2004. PMID: 15051776 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters